NCT04327492

Brief Summary

Establish and validate biomarkers which improve the predictive value of current risk stratification models for patients benefiting from carotid revascularization, outperform existing biomarkers, and reach clinical application standards.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
272

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 31, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1.8 years

First QC Date

March 26, 2020

Last Update Submit

March 26, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Stroke

    30 days, long-term

  • Clavien dindo>3

    30 days, long-term

  • MACE

    AMI, stroke, Major adverse limb event, acute hear faillure hospitalization, all cause mortality

    30 days, long-term

Study Arms (1)

Carotid endarterectomy

This study is a non-interventional prospective cohort study. The population corresponds to patients submitted to CEA under regional anesthesia. Consecutive patients from a tertiary referral center who undergo CEA for carotid artery stenosis (CS) will be prospectively recruited. The expected patient follow-up will be of 5 years. The demographics will be recorded in a prospective, protected database. Blood samples will be collected in clot activator serum tubes at three timepoints: timepoint 1 - before surgery (until 15 days before surgery); timepoint 2 up to 48h postoperatively; timepoint

Diagnostic Test: Biomarker - FGF 23; troponin I; PCR - high sensitivity; BNP

Interventions

peak wave velocity; gray weale plaque classification

Carotid endarterectomy

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients selected and submited to carotid endarterectomy under regional anesthesia

You may qualify if:

  • \- consecutive patients from a tertiary referral center who undergo CEA for carotid artery stenosis (CS) under regional anesthesia

You may not qualify if:

  • general anesthesia
  • carotid stenting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Medicina da Universidade do Porto

Porto, 4200-319, Portugal

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood sample. atherosclerotic plaque

MeSH Terms

Conditions

Carotid Stenosis

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Joao R Neves, MD, MSC, MPH

    Universidade do Porto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joao R Neves, MD, MSC; MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSC; MPH, FEBVS

Study Record Dates

First Submitted

March 26, 2020

First Posted

March 31, 2020

Study Start

April 1, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

March 31, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations